Pre-transplant recipient-donor interaction: a prognostic indicator in living related kidney transplantation?

Based on the hypothesis that not only genetically determined immune characteristics, but also psychosocial and especially interpersonal factors may influence the outcome in living related kidney transplantation, we investigated the type of relationship between recipient and donor, and its association with graft prognosis. The study group consisted of 154 kidney transplant candidates and their selected donors. Donor and recipient were assessed prospectively prior to transplantation using an interactional task (Usandivaras Marbles Test) and assigned to one of four groups, according to their pattern of contact. Kidney survival was calculated for each test group, and results compared by life table methods and logistic regression. The group that showed progression from initial contact avoidance or enmeshment to contact with boundaries had a significantly better outcome than the other groups (no change or loss of contact with boundaries). Differences could not be related to other variables such as age, sex, sex difference, relationship, HLA-matching, and treatment.

[Study of intestinal permeability in celiac disease with 51 Cr-EDTA]. / Estudio de la permeabilidad intestinal en enfermos celiacos con EDTA-CR51.

Intestinal permeability was studied in a group of 10 children diagnosed of coeliac disease either when they presented an intestinal villi atrophy while receiving a gluten-containing diet and after, when they had a normal mucosa with the withdrawal of gluten from the diet. Ten healthy children served as controls. The 51 Cr-EDTA (51 Cr-ethylenediaminetetraacetate) was used as probe molecule and it was administered orally. Its urinary excretion showed clear differences between patients with an altered intestinal biopsy and those with a normal histopathology. The excretion of 51 Cr-EDTA remained elevated in celiac patients with a gluten-free diet and normal villi.

Estudio de la permeabilidad intestinal en enfermos celíacos con EDTA-Cr51 / Study of intestinal permeability in celiac disease with 51 Cr-EDTA

Presentamos un estudio sobre la permeabilidad intestinal en una serie de diez niños diagnosticados de enfermedad celiaca cuando tomaban una dieta con gluten y tenían una atrofia severa de las vellosidades intestinales y posteriormente durante un período con dieta sin gluten y vellosidades intestinales normales. Tomamaos como grupo control a diez niños sanos. Se utilizó como marcador el EDTA-Cr51 (Etiléndiaminotetracetato Cr51) administrado por vía oral. Su excreción urinaria estaba signficativamente elevada en los pacientes con biopsia alterada, manteniéndose una moderada elevación en los pacientes celiacos con dieta exenta de gluten y sin atrofia de las vellosidades

Estudio de la permeabilidad intestinal en enfermos celíacos con EDTA-Cr51 / Study of intestinal permeability in celiac disease with 51 Cr-EDTA

Presentamos un estudio sobre la permeabilidad intestinal en una serie de diez niños diagnosticados de enfermedad celiaca cuando tomaban una dieta con gluten y tenían una atrofia severa de las vellosidades intestinales y posteriormente durante un período con dieta sin gluten y vellosidades intestinales normales. Tomamaos como grupo control a diez niños sanos. Se utilizó como marcador el EDTA-Cr51 (Etiléndiaminotetracetato Cr51) administrado por vía oral. Su excreción urinaria estaba signficativamente elevada en los pacientes con biopsia alterada, manteniéndose una moderada elevación en los pacientes celiacos con dieta exenta de gluten y sin atrofia de las vellosidades (AU)

Estudio de la permeabilidad intestinal en enfermos celiacos con EDTA-CR51. / [Study of intestinal permeability in celiac disease with 51 Cr-EDTA]

Intestinal permeability was studied in a group of 10 children diagnosed of coeliac disease either when they presented an intestinal villi atrophy while receiving a gluten-containing diet and after, when they had a normal mucosa with the withdrawal of gluten from the diet. Ten healthy children served as controls. The 51 Cr-EDTA (51 Cr-ethylenediaminetetraacetate) was used as probe molecule and it was administered orally. Its urinary excretion showed clear differences between patients with an altered intestinal biopsy and those with a normal histopathology. The excretion of 51 Cr-EDTA remained elevated in celiac patients with a gluten-free diet and normal villi.

Clinical trial of young red cell transfusions.

The lower mean cell age and prolonged 51Cr-labeled red cell survival of the top layer of centrifuged red blood cells suggest that this product may reduce blood requirements in patients with transfusion-dependent anemias. In a prospective clinical trial, we compared the effect of regular administration of young red cells with that associated with use of conventional frozen cells. Six patients with thalassemia major received 192 units of young red cells prepared from single donor units of whole blood using the IBM 2991 Cell Processor. The mean transfusion requirement to maintain the hemoglobin level greater than 9.0 gm/dl was 110 +/- 17 ml RBC/kg during the year of young cell transfusions, in comparison with 130 +/- 20 and 131 +/- 23 ml RBC/kg when conventional frozen cells were administered in the years before and after the young cell trial, respectively. Blood requirements in individual patients were reduced by 8% to 24% (mean 15.8%); the hemoglobin level remained constant. Although young cells of consistent quality can be prepared regularly in a clinical setting with little difficulty, the cost of the product is high and the effect on transfusion requirements is less than predicted from studies in vitro and from labeling experiments.